SOPHiA GENETICS S.A.
SOPH · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $209 | $222 | $205 |
| - Cash | $82 | $95 | $69 | $80 |
| + Debt | $61 | $64 | $30 | $30 |
| Enterprise Value | – | $178 | $184 | $154 |
| Revenue | $19 | $18 | $18 | $18 |
| % Growth | 6.2% | 3.1% | 0.3% | – |
| Gross Profit | $13 | $12 | $12 | $12 |
| % Margin | 66.3% | 67% | 68.7% | 68.2% |
| EBITDA | -$17 | -$19 | -$14 | -$8 |
| % Margin | -88.6% | -102.2% | -78.3% | -44.8% |
| Net Income | -$20 | -$22 | -$17 | -$15 |
| % Margin | -102.9% | -122.3% | -97.8% | -85.5% |
| EPS Diluted | -0.3 | -0.33 | -0.26 | -0.23 |
| % Growth | 9.1% | -26.9% | -13% | – |
| Operating Cash Flow | -$9 | -$8 | -$11 | -$11 |
| Capital Expenditures | -$0 | -$2 | -$1 | -$2 |
| Free Cash Flow | -$9 | -$10 | -$12 | -$13 |